HealthPeak (DOC) Q2 2026: $1B Brookfield JV Unlocks Capital, Fuels Outpatient and Lab Expansion
HealthPeak’s $1 billion partnership with Brookfield marks a capital inflection, positioning the company for outsized growth in outpatient and life science real estate. Strategic joint ventures and disciplined capital allocation are driving portfolio expansion while maintaining balance sheet strength. With improving lab demand and accelerating senior housing growth, HealthPeak is executing on multiple fronts ahead of sector recovery.
Summary
- Capital Access Deepens: Brookfield JV and Blackstone partnership expand HealthPeak’s growth options.
- Leasing Momentum Builds: Outpatient and lab segments both posted sequential occupancy gains.
- Balance Sheet Flexibility: Low leverage and cash proceeds enable opportunistic investment across cycles.
Business Overview
HealthPeak Properties (DOC) is a diversified healthcare real estate investment trust (REIT) focused on three core segments: outpatient medical, life science (lab), and senior housing. The company generates revenue primarily through long-term leases to healthcare providers, biotech firms, and senior living operators. HealthPeak’s business model leverages strategic partnerships and deep sector relationships to source development and acquisition opportunities, while also internalizing property and asset management to drive operational efficiency and tenant retention.
Performance Analysis
HealthPeak delivered solid top-line and operational results in Q2 2026, supported by robust leasing in outpatient and lab segments and a transformative $1 billion joint venture with Brookfield. Outpatient medical saw 1.2 million square feet of leases executed, with tenant retention at 80% and cash releasing spreads of 5%, maintaining a multi-year trend of above-peer performance. Sequential occupancy rose to 90.7%, and the leasing pipeline suggests further acceleration into 2027.
In life science, occupancy improved by 80 basis points to 78.5%, with 381,000 square feet of executed leases, 60% of which were new. The lab pipeline remains healthy, with 500,000 square feet under letter of intent (LOI), and management expects modest occupancy gains through year-end. Senior housing, through Janus Living, posted standout 45% revenue growth and 19% NOI growth, with the portfolio set to double in size this year. The $1 billion Brookfield JV, alongside an existing Blackstone partnership, provides HealthPeak with both growth capital and operational control, allowing for continued portfolio expansion and strategic capital recycling.
- JV Capitalization Accelerates: The Brookfield JV recapitalized 5.6 million square feet, unlocking $1 billion in proceeds and maintaining 51% ownership for HealthPeak.
- Outpatient Leasing Outperforms: Cash releasing spreads held at 5%, with low tenant improvements and 3% escalators, reflecting strong fundamentals and disciplined execution.
- Life Science Recovery Emerges: Occupancy gains and robust pipelines in core markets signal early signs of sector stabilization and future NOI growth.
HealthPeak’s capital recycling and debt repayment further improved net leverage to 4.7 times, with $4.1 billion in liquidity, reinforcing its ability to pursue acquisitions, developments, or buybacks as market conditions warrant.
Executive Commentary
"The downturn also provided a window to redefine our company and reset the competitive landscape. We were bold and strategic, including a $5 billion merger and a billion dollar IPO. Today, we're a bigger and better company because of those decisive actions."
Scott Brinker, President & Chief Executive Officer
"With the leadership from our investment team, we've demonstrated our ability to execute scale transactions and partner with leading institutional investment managers. From a structured perspective, HealthSeek will retain a 51% ownership interest in a 5.6 million square foot outpatient medical portfolio and raise a billion dollars of cash proceeds."
Kelvin Murphy, Executive Vice President & Chief Financial Officer
Strategic Positioning
1. Capital Partnerships Redefine Growth Trajectory
HealthPeak’s joint ventures with Brookfield and Blackstone provide alternative equity sources, enabling the company to scale outpatient and lab portfolios without diluting operational control. The Brookfield structure, with a 51% retained stake and a future buyback option, offers both immediate capital and long-term strategic flexibility.
2. Outpatient Medical: Scaling in High-Barrier Markets
Market-leading share in Atlanta and deep relationships with health systems like Northside are driving recurring development opportunities. Outpatient leasing outpaces industry averages, with disciplined tenant improvement spend and strong renewal economics underpinning internal growth.
3. Life Science: Positioned for Consolidation and Recovery
HealthPeak is shifting from development to acquisition in life science, leveraging its platform to pursue distressed or underperforming assets in core markets such as the Bay Area and San Diego. The company’s ability to capture a disproportionate share of leasing demand in these markets is a competitive differentiator as sector fundamentals improve.
4. Senior Housing: Rapid Portfolio Expansion
Through Janus Living, HealthPeak is doubling its senior housing exposure in 2026, with a creative deal structure that aligns incentives and accelerates earnings growth. The sector’s 45% revenue growth and expanding operator base reflect robust demand and execution.
5. Balance Sheet Strength Enables Opportunism
With leverage below five times and $4.1 billion in liquidity, HealthPeak can remain patient, deploying capital only when returns are compelling. The company’s capital allocation discipline is evident in its selective buybacks and focus on high-return development and acquisition opportunities.
Key Considerations
This quarter marks a strategic turning point for HealthPeak, as the company leverages institutional capital partnerships and operational momentum to position for sector recovery and long-term growth. The following considerations are central to the investment thesis:
Key Considerations:
- JV Structures Drive Value: The Brookfield and Blackstone partnerships allow HealthPeak to scale while preserving control and upside through buyback options and operating partner fees.
- Leasing Execution Sustains Growth: Outpatient and lab portfolios are capturing market share, with low capital intensity and strong renewal spreads supporting NOI expansion.
- Acquisition Pipeline in Focus: Life science M&A is shifting from development to acquisition, with HealthPeak targeting core assets where its platform adds value.
- Senior Housing Acceleration: Janus Living’s rapid portfolio growth and strong revenue trajectory diversify earnings and capitalize on demographic tailwinds.
- Balance Sheet Optionality: Low leverage and ample liquidity enable HealthPeak to act opportunistically as market dislocation creates new entry points.
Risks
Key risks include sector-specific volatility in life science demand, particularly in Boston where supply overhang remains a headwind. Outpatient and senior housing growth are reliant on continued tenant health and demographic trends. Rising interest rates and capital market volatility could impact acquisition economics and refinancing costs. While JV structures offer flexibility, they may introduce complexity in asset management and future buyback execution.
Forward Outlook
For Q3 2026, HealthPeak guided to:
- Modest sequential occupancy gains in both lab and outpatient portfolios
- Continued capital recycling and disciplined deployment of liquidity
For full-year 2026, management raised FFO guidance by 2 cents to $1.73-$1.77 per share:
- Driven by higher same-store NOI in lab and senior housing (each up 200 basis points at midpoint)
Management emphasized that leasing pipelines remain robust, and capital allocation will focus on high-return acquisitions, selective development, and patient deployment of available liquidity.
- Lab occupancy is expected to improve modestly through year-end
- Senior housing portfolio will nearly double in size in 2026
Takeaways
HealthPeak’s multi-pronged strategy—anchored by institutional JVs, operational outperformance, and a fortress balance sheet—positions the company to capitalize on sector recovery and market dislocation.
- Capital Partnerships Are a Game Changer: The Brookfield and Blackstone JVs unlock growth while preserving HealthPeak’s operating leverage and optionality.
- Operational Execution Drives Earnings: Sustained leasing momentum and disciplined capital spend in outpatient and lab are fueling NOI growth ahead of sector inflection.
- Watch for M&A and Sector Recovery: Investors should monitor HealthPeak’s ability to consolidate core lab assets and further scale senior housing as market conditions evolve.
Conclusion
HealthPeak’s Q2 demonstrates a decisive pivot toward growth, with capital partnerships and operational execution setting the stage for outperformance as healthcare real estate cycles recover. The company’s balance sheet and JV structures provide both resilience and upside optionality.
Industry Read-Through
HealthPeak’s results signal renewed confidence in healthcare real estate, especially as large institutional investors seek exposure to outpatient and life science assets through operating partnerships. The shift from development-led to acquisition-driven growth in life science is likely to accelerate sector consolidation, favoring platforms with scale, balance sheet strength, and local operating expertise. Senior housing’s rapid expansion and robust revenue growth at Janus Living highlight demographic tailwinds and the potential for creative deal structures to unlock value. For peers and investors, the quarter underscores the importance of capital flexibility, disciplined execution, and partnership-driven growth as key differentiators in a volatile market.